What is National Labs?
National Labs, headquartered in Hayward, CA, is at the forefront of revolutionizing behavioral health and alcohol testing through its proprietary all-in-one dried blood spot solution, SpotCheck Plus. The company also provides comprehensive COVID-19 testing services, collaborating with various organizations to ensure accurate and timely results. Their advanced toxicology testing, supported by a PhD-driven technical team, delivers high accuracy and tailored services crucial for patient treatment plans. National Labs is dedicated to being a reliable partner in the healthcare sector, emphasizing precision, dependability, and superior quality in its offerings.
How much funding has National Labs raised?
National Labs has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in National Labs
PPP
Public-Private Partnership
What's next for National Labs?
The company's large-scale late-stage funding context suggests a focus on scaling operations, expanding market reach, and potentially further developing its innovative testing technologies. This strategic capital infusion is expected to accelerate National Labs' growth initiatives, solidifying its role as a key player in the behavioral health and diagnostic testing landscape. Future developments may include broader adoption of SpotCheck Plus and enhanced service offerings in response to evolving healthcare demands.
See full National Labs company page
